Cocaine Addiction Treatment and Home Remedies: Use of the Scopolamine Transdermal Patch

REFERENCES

• Adinoff, B., Devous, M. D., Sr., Williams, M. J., Best, S. E., Harris, T. S., Minhajuddin, A., (2010). Altered neural cholinergic receptor systems in cocaine-addicted subjects. Neuropsychopharmacology, 35, 1485–1499.
   PubMedGoogle Scholar
• Basile, A. S., Fedorova, I., Zapata, A., Liu, X., Shippenberg, T., Duttaroy, A., (2002). Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia. Proceedings of the National Academy of Sciences of the United States of America, 99, 11452–11457.
   Google Scholar
• Berlanga, M. L., Olsen, C. M., Chen, V., Ikegami, A., Herring, B. E., Duvauchelle, C. L., (2003). Cholinergic interneurons of the nucleus accumbens and dorsal striatum are activated by the self-administration of cocaine. Neuroscience, 120, 1149–1156.
   PubMedGoogle Scholar
• Bolam, J. P., Francis, C. M., & Henderson, Z. (1991). Cholinergic input to dopaminergic neurons in the substantia nigra: A double immunocytochemical study. Neuroscience, 41, 483–494.
   PubMed Web of Science ®Google Scholar
• Chaisson, R. E., Bacchetti, P., Osmond, D., Brodie, B., Sande, M. A., & Moss, A. R. (1989). Cocaine use and HIV infection in intravenous drug users in San Francisco. The Journal of the American Medical Association, 261, 561–565.
   PubMed Web of Science ®Google Scholar
• Devlin, R. J., & Henry, J. A. (2008). Clinical review: Major consequences of illicit drug consumption. Critical Care, 12, 202.
   PubMed Web of Science ®Google Scholar
• Filip, M., Frankowska, M., Zaniewska, M., Gołda, A., & Przegaliński, E. (2005). The serotonergic system and its role in cocaine addiction. Pharmacological Reports, 57, 685–700.
   PubMed Web of Science ®Google Scholar
• Fink-Jensen, A., Fedorova, I., Wörtwein, G., Woldbye, D. P., Rasmussen, T., Thomsen, M., (2003). A role for M5 muscarinic aetylcholine. Journal of Neuroscience Research, 74, 91–96.
   PubMedGoogle Scholar
• Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R.. (2007). New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology, 47, 681–698.
   PubMed Web of Science ®Google Scholar
• Flynn, D. D., Vaishnav, A. A., & Mash, D. C. (1992). Interactions of cocaine with primary and secondary recognition sites on muscarinic receptors. Molecular Pharmacology, 41, 736–742.
   PubMed Web of Science ®Google Scholar
• Forster, G. L., Yeomans, J. S., Takeuchi, J., & Blaha, C. D. (2001). M5 muscarinic receptors are required for prolonged accumbal dopamine release after electrical stimulation of the pons in mice. The Journal of Neuroscience, 22, RC190.
   Google Scholar
• Gambelunghe, C., Marsili, R., Aroni, K., Bacci, M., & Rossi, R. (2013). GC-MS and GC-MS/MS in PCI mode determination of mescaline in peyote tea and in biological matrices. Journal of Forensic Sciences, 58, 270–278.
   PubMedGoogle Scholar
• Kaye, S., & Darke, S. (2004). Injecting and non-injecting cocaine use in Sydney, Australia: Physical and psychological morbidity. Drug and Alcohol Review, 23, 391–398.
   PubMed Web of Science ®Google Scholar
• Leri, F., Bruneau, J., & Stewart, J. (2003). Understanding polydrug use: Review of heroin and cocaine co-use. Addiction, 98, 7–22.
   PubMed Web of Science ®Google Scholar
• Lester, D. B., Miller, A. D., & Blaha, C. D. (2010). Muscarinic receptor blockade in the ventral tegmental area attenuates cocaine enhancement of laterodorsal tegmentum stimulation-evoked accumbens dopamine efflux in the mouse. Synapse, 64, 216–223.
   PubMedGoogle Scholar
• Lin, Y. G., Chen, P. H., Chang, F. Y., Wu, L. T., Liao, K. Y., & Wu, T. C. (2011). Delirium due to scopolamine patch in a 4-year-old boy. Journal of the Formosan Medical Association, 110, 208–211.
   PubMedGoogle Scholar
• Pépin, G., & Gaillard, Y. (1997). Concordance between self-reported drug use and findings in hair about cocaine and heroin. Forensic Science International, 8, 37–41.
   Google Scholar
• Pettit, H. O., & Justice, J. B., Jr. (1989). Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis. Pharmacology Biochemistry and Behavior, 34, 899–904
   PubMed Web of Science ®Google Scholar
• Prakash, A., & Das, G. (1993). Cocaine and the nervous system. International Journal of Clinical Pharmacology Therapy and Toxicology, 31, 575–581.
   PubMed Web of Science ®Google Scholar
• Raffa, R. B. (2009). The M5 muscarinic receptor as possible target for treatment of drug abuse. Journal of Clinical Pharmacy and Therapeutics, 34, 623–629.
   PubMed Web of Science ®Google Scholar
• Renner, U. D., Oertel, R., & Kirch, W. (2005). Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Therapeutic Drug Monitoring, 27, 655–665.
   PubMed Web of Science ®Google Scholar
• Sharkey, J., Ritz, M. C., Schenden, J. A., Hanson, R. C., & Kuhar, M. J. (1988). Cocaine inhibits muscarinic cholinergic receptors in heart and brain. The Journal of Pharmacology and Experimental Therapeutics, 246, 1048–1052.
   PubMed Web of Science ®Google Scholar
• Shorter, D., & Kosten, T. R. (2011). Novel pharmacotherapeutic treatments for cocaine addiction. BMC Medicine, 9, 119.
   PubMed Web of Science ®Google Scholar
• Sun, W., Xue, Y., Huang, Z., & Steketee, J. D. (2010). Regulation of cocaine-reinstated drug-seeking behavior by kappa-opioid receptors in the ventral tegmental area of rats. Psychopharmacology, 210, 179–188.
   PubMedGoogle Scholar
• Tassiopoulos, J., Bernstein, T., Heeren, S., Levenson, R., Hingson, E., & Bernstein, E. (2004). Hair testing and self-report of cocaine use by heroin users. Addiction, 99, 590–597.
   PubMed Web of Science ®Google Scholar
• Thomsen, M., Woldbye, D. P., Wörtwein, G., Fink-Jensen, A., Wess, J., & Caine, S. B. (2005). Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. The Journal of Neuroscience, 25, 8141–8149.
   PubMedGoogle Scholar
• Vignali, C., Stramesi, C., Vecchio, M., & Groppi, A. (2012). Hair testing and self-report of cocaine use. Forensic Science International, 215, 77–80.
   PubMedGoogle Scholar
• Welp, E. A., Bosman, I., Langendam, M. W., Totté, M., Maes, R. A., & van Ameijden, E. J. (2003). Amount of self-reported illicit drug use compared to quantitative hair test results in community-recruited young drug users in Amsterdam. Addiction, 98, 987–994.
   PubMed Web of Science ®Google Scholar
• Williams, M. J., & Adinoff, B. (2008). The role of acetylcholine in cocaine addiction. Neuropsychopharmacology, 33, 1779–1797.
   PubMed Web of Science ®Google Scholar
• Xiang, X. H., Wang, H. L., Wu, W. R., Guo, Y., Cao, D. Y., Wang, H. S., (2006). Ethological analysis of scopolamine treatment or pretreatment in morphine dependent rats. Physiology & Behavior, 15, 183–190.
   Google Scholar
• Yang, G. D., Xu, K., & Luo, Q. (1996). Clinical study of scopolamine detoxification for the treatment of heroin addicts. Zhonghua Yi Xue Za Zhi, 76, 141–144.
   PubMedGoogle Scholar
• Yang, G. D., Zhou, W. H., & Xu, K. (1999). The combined use of scopolamine, naltrexone and naloxone as a rapid, safe and effective detoxification treatment for heroin addicts. Zhonghua Yi Xue Za Zhi, 79, 679–682.
   PubMedGoogle Scholar
• Yee, J., Famous, K. R., Hopkins, T. J., McMullen, M. C., Pierce, R. C., & Schmidt, H. D. (2011). Muscarinic acetylcholine receptors in the nucleus accumbens core and shell contribute to cocaine priming-induced reinstatement of drug seeking. European Journal of Pharmacology, 650, 596–604.
   PubMedGoogle Scholar